Mar 05, 2020 / 09:30PM GMT
Operator
Good afternoon, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Year-End 2019 Results Conference Call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, Dr. Glenn Schulman, Head of Investor Relations. Thank you. You may begin.
Glenn Schulman - Aurinia Pharmaceuticals Inc. - SVP of Corporate Communications & IR
Thanks, Diego, and good afternoon, everyone. Welcome to Aurinia's Year-End 2019 Results Conference Call.
Joining me on the call today from the Aurinia team are Mr. Peter Greenleaf, President and CEO; our CFO, Dennis Bourgeault; Dr. Neil Solomons, our Chief Medical Officer; Mr. Michael Martin, Chief Operating Officer; and Mr. Max Colao, our recently appointed Chief Commercial Officer. Following some prepared remarks, the team will also be available for questions during the Q&A session.
So this afternoon, we issued our press release detailing fourth quarter and year-end 2019 financial results. The press release and associated financial
Q4 2019 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Mar 06, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers